Search research articles
Contact Us
Filters
Showing results (91-100 of 466) with videos related to
Page
of 47
Sort By:
Antimicrobial Agents and Chemotherapy
|
August 25, 2010
Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis
Federico Pea, Mario Furlanut, Piergiorgio Cojutti, et al.
Antibiotics (Basel, Switzerland)
|
April 28, 2023
Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis
Milo Gatti, Giacomo Fornaro, Zeno Pasquini, et al.
Antimicrobial Agents and Chemotherapy
|
July 29, 2005
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure
Federico Pea, Pierluigi Viale, Daniela Damiani, et al.
Antimicrobial Agents and Chemotherapy
|
February 27, 2024
Balancing the scales: achieving the optimal beta-lactam to beta-lactamase inhibitor ratio with continuous infusion piperacillin/tazobactam against extended spectrum beta-lactamase producing <i>Enterobacterales</i>
Pier Giorgio Cojutti, Manjunath P Pai, Tommaso Tonetti, et al.
International Journal of Antimicrobial Agents
|
May 16, 2023
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF)
Milo Gatti, Matteo Rinaldi, Tommaso Tonetti, et al.
International Journal of Antimicrobial Agents
|
February 22, 2023
A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections
Milo Gatti, Vincent H Tam, Paolo Gaibani, et al.
The Journal of Antimicrobial Chemotherapy
|
February 10, 2026
Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of orthotopic liver transplant recipients
Milo Gatti, Matteo Rinaldi, Cristiana Laici, et al.
Drugs in Context
|
March 27, 2026
Evaluating oritavancin for Gram-positive infections: a systematic review of on-label and off-label use
Alex Soriano, Carlo Tascini, Marco Falcone, et al.
Journal of Medical Microbiology
|
April 10, 2026
Comparable efficacy of bictegravir/emtricitabine/tenofovir alafenamide and doravirine/lamivudine/tenofovir disoproxil fumarate in therapy-naive Human Immunodeficiency Virus adults with very high baseline viraemia
Leonardo Calza, Maddalena Giglia, Claudio Rigamonti, et al.
Antiviral Therapy
|
September 26, 2015
Improvement in renal function and bone mineral density after a switch from tenofovir/emtricitabine plus ritonavir-boosted protease inhibitor to raltegravir plus nevirapine: a pilot study
Leonardo Calza, Eleonora Magistrelli, Vincenzo Colangeli, et al.
Page
of 47
Search research articles
Search
Showing results (91-100 of 466) with videos related to
Sort By:
Page
of 47
Antimicrobial Agents and Chemotherapy
|
August 25, 2010
Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis
Federico Pea, Mario Furlanut, Piergiorgio Cojutti, et al.
Antibiotics (Basel, Switzerland)
|
April 28, 2023
Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis
Milo Gatti, Giacomo Fornaro, Zeno Pasquini, et al.
Antimicrobial Agents and Chemotherapy
|
July 29, 2005
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure
Federico Pea, Pierluigi Viale, Daniela Damiani, et al.
Antimicrobial Agents and Chemotherapy
|
February 27, 2024
Balancing the scales: achieving the optimal beta-lactam to beta-lactamase inhibitor ratio with continuous infusion piperacillin/tazobactam against extended spectrum beta-lactamase producing <i>Enterobacterales</i>
Pier Giorgio Cojutti, Manjunath P Pai, Tommaso Tonetti, et al.
International Journal of Antimicrobial Agents
|
May 16, 2023
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF)
Milo Gatti, Matteo Rinaldi, Tommaso Tonetti, et al.
International Journal of Antimicrobial Agents
|
February 22, 2023
A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections
Milo Gatti, Vincent H Tam, Paolo Gaibani, et al.
The Journal of Antimicrobial Chemotherapy
|
February 10, 2026
Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion ceftazidime-avibactam in a case series of orthotopic liver transplant recipients
Milo Gatti, Matteo Rinaldi, Cristiana Laici, et al.
Drugs in Context
|
March 27, 2026
Evaluating oritavancin for Gram-positive infections: a systematic review of on-label and off-label use
Alex Soriano, Carlo Tascini, Marco Falcone, et al.
Journal of Medical Microbiology
|
April 10, 2026
Comparable efficacy of bictegravir/emtricitabine/tenofovir alafenamide and doravirine/lamivudine/tenofovir disoproxil fumarate in therapy-naive Human Immunodeficiency Virus adults with very high baseline viraemia
Leonardo Calza, Maddalena Giglia, Claudio Rigamonti, et al.
Antiviral Therapy
|
September 26, 2015
Improvement in renal function and bone mineral density after a switch from tenofovir/emtricitabine plus ritonavir-boosted protease inhibitor to raltegravir plus nevirapine: a pilot study
Leonardo Calza, Eleonora Magistrelli, Vincenzo Colangeli, et al.
Page
of 47